India’s Bharat Biotech says its Covaxin booster dose offers long-term protection
Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech’s COVID-19 vaccine called Covaxin during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, Jan. 16, 2021. (REUTERS)
India’s Bharat Biotech said on Saturday a booster dose of its COVID-19 vaccine Covaxin offered long-term protection from severe disease in a trial.
The company said a booster dose was given to trial participants six months after they received their second dose.
ADVERTISEMENT
FEATURED STORIES
Subscribe to our daily newsletter
Read Next
EDITORS' PICK
MOST READ
Don't miss out on the latest news and information. 
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.
